Boston University appoints new Chief of Preventive Medicine

Donald M. Lloyd-Jones, MD, ScM is also a national leader in clinical approaches and public health and works to promote heart health and prevent cardiovascular diseases.

Study in US: Boston University has announced that Donald M. Lloyd-Jones, MD, ScM, will be appointed in the role of principal investigator of the Framingham Heart Study, director of the Framingham Center for Population and Prevention Science, and chief of the section of preventive medicine within the department of medicine at the Chobanian & Avedisian School of Medicine and Boston Medical Center. He will join this new position effective from January 1, 2025.

while commenting on his appointment, he said, “I am truly excited to return to the Framingham Study and BU, where I began my research career in earnest. I am mindful of the incredible legacy of past leaders, who are all giants in our field, like Drs. Dawber, Kannel, Castelli, Wolf and Ramachandran. I am also excited to partner with Drs. Dan Levy, Joanne Murabito, George O’Connor and Emelia Benjamin, who have been ongoing leaders of the Framingham studies for decades. We have an incredible team, and remarkable opportunities to take Framingham and BU to new heights.”

David C. Goff, MD, PhD, director of the division of cardiovascular sciences at the National Heart, Lung, and Blood Institute, part of the National Institutes of Health said, “Over decades, the Framingham Heart Study has produced great learnings that further our understanding of cardiovascular disease in America. This transition to new leadership retains the depth of familiarity with the study while advancing the latest science and innovations in epidemiology. We have great confidence in Dr. Lloyd-Jones’ ability to lead the Framingham Heart Study into a new era of scientific excellence."

About Donald M. Lloyd-Jones

Previously from 2012-20, he was working with Northwestern University Clinical and Translational Sciences (NUCATS) Institute as senior associate dean for clinical and translational research and PI/director. From 2021 to 22, he was the national president of the American Heart Association.

He completed his BA degree from Swarthmore College and his MD from Columbia University College of Physicians and Surgeons. From Harvard TH Chan School of Public Health, he did a master of science in epidemiology. At Massachusetts General Hospital (MGH), he completed a residency in internal medicine and served as chief medical resident.

Read more:

• Kelley School of Business Introduces Global Case Competition to Boost MSIS Program
• Macquarie University researchers named Eureka Prize finalists